Range of a-mannosidase activity (nmol/h per 10' cells) Fig. 1 . Changes in a-mannosidase levels in deficientfibroblasts after direct interaction with lymphocytes Cytochemical analysis of lysosomal a-mannosidase levels. The distribution of enzyme activity among the population of individual cells is shown for normal fibroblasts and for mannosidosis fibroblasts cultured alone and co-cultured with mouse lymphocytes. Numbers in parentheses represent the mean a-mannosidase activity, as determined by biochemical assay of fibroblast cell extracts. co-culture with lymphocytes was unaffected by 5 m~-mannose 6-phosphate, whereas endocytosis of normal fibroblast a-mannosidase decreased by 93% in the presence of this inhibitor. Moreover, enzyme acquisition from lymphocytes required direct cell-tocell contact, since when the two types of cell were cultured together in the same dish but separated by a multipore filter, there was no increase in fibroblast a-mannosidase activity.
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co-culture with lymphocytes was unaffected by 5 m~-mannose 6-phosphate, whereas endocytosis of normal fibroblast a-mannosidase decreased by 93% in the presence of this inhibitor. Moreover, enzyme acquisition from lymphocytes required direct cell-tocell contact, since when the two types of cell were cultured together in the same dish but separated by a multipore filter, there was no increase in fibroblast a-mannosidase activity.
The biochemical characteristics of the enzyme acquired by deficient human fibroblasts during co-culture with murine lymphocytes were next examined. Two major forms of lysosomal a-mannosidase, designated A and B, are present in cells of human origin, both fibroblasts and lymphocytes, whereas the enzyme in murine lymphocytes is present almost entirely in the B-form. These forms are readily distinguishable by ion-exchange chromatography on DEAEcellulose. The present studies show that the enzyme extracted from deficient human fibroblasts after co-culture with murine lymphocytes is exclusively of the B-type. Moreover, polyacrylamide-gel electrophoresis has confirmed that the acquired enzyme had an identical mobility to that present in the donor lymphocytes, readily distinguishable from that of normal human fibroblast lysosomal a-mannosidase.
Preliminary experiments have also been undertaken in order to identify the subcellular distribution of murine enzyme within the recipient human fibroblast. This was done by ultracentrifugation of extracts of co-cultured mannosidosis fibroblasts in a Percoll gradient (Rome et al., 1979) . In this case a major proportion of the activity is associated with a low-density ('light') lysosomal fraction, comparable with the distribution of the enzyme in the lymphocytes themselves. In contrast, the distribution of enzyme activity after endocytosis of high uptake a-mannosidase is more comparable with that of endogenous enzyme in normal human fibroblasts, where approximately 60% is associated with the high-density ('heavy') lysosomal fraction.
The present results show, as has previously been reported for P-glucuronidase, that a-mannosidase is transferred directly from donor lymphocytes to recipient fibroblasts by a process which does not involve receptor-mediated endocytosis and which requires cell-to-cell contact. lumen, is not clear. The lysosomotropic drug chloroquine has a marked effect on the labelling of the intracellular cystine pool in cystinotic cells (Danpure, 1981) , and the present study investigates the mechanisms of action of chloroquine in terms of the intracellular translocation of 3sS derived from exogenous [3sS]cystine. Monolayers of cystinotic and normal skin fibroblasts were grown to confluence in Ham's F10 medium supplemented with 15% foetal calf serum. The cells were preincubated in medium f 20p~-chloroquine for 24 h. The medium was then spiked with [35S]cystine (final concentration 3-50 pCi/ml, 1 3 0~~) .
After various periods of time, from 3min to 4 days, the cells were washed in situ with ice-cold phosphate-buffered saline and scraped off into 0.25 Msucrose containing I mM-Na,EDTA, pH7.2, and I mM-Nethylmaleimide. They were disrupted in a Dounce homogenizer and post-nuclear supernatants (6OOg for l0min) were layered onto sucrose gradients (sp. gravity = 1.05-1.30 containing 1 mM-Na2EDTA, pH 7.2), which were centrifuged at 72000g for 60min at 4°C in a Sorvall TV-865 B vertical pocket rotor. Fractions were collected and, after removing samples for assaying the lysosomal marker &N-acetylglucosaminidase, N-ethylmaleimide was added to a final concentration of 10mM. The samples were then sonicated and sulphosalicylic acid was added (to a concentration of 5%) to precipitate the proteins. The supernatants were assayed for )% and selected fractions were chromatographed for 3sS-metabolites (Danpure, 1981) .
In cystinotic fibroblasts, chloroquine ( 2 0~~) affects the labelling of the intracellular cystine pool biphasically depending on the time the cells are incubated with [3sS]cystine. After short periods of labelling (< 1-8 h), the intracellular [35S]cystine pool is decreased by chloroquine, whereas after longer periods (224h) it is increased. Other pools, except to a smaller extent [3SS]cysteine, are unaffected.
After labelling for 3min, chloroquine decreased the level of acid-soluble radioactivity in the lysosomes of cystinotic cells, while after 4 days it increased lysosomal radioactivity ( Table 1) . In cystinotic cells most of the lysosomal 3sS was in the form of cystine. Chromatographic analysis showed that after 3 min labelling, chloroquine decreased the proportion of [35S]cysteine in the lysosomes, while after 4 days it increased the proportion of [3SS]cystine. The distribution of 3sS among the various cytosolic metabolites was largely unaffected by the presence of chloroquine.
In normal cells the sedimentable acid-soluble 35S (coeluting with /3-N-acetylglucosaminidase) was entirely as cysteine. After both 3min and 1 h labelling, chloroquine increased this radioactivity (Table 1) . However, in normal cells, whereas chloroquine decreased the equilibrium density of the lysosomes from 1.21 to 1.14g/ml, it did not affect the 3sS peak, mainly [3SS]cysteine, which remained at 1.21g/ml ( Table 1) .
In the short term most of the [35S]cystine is probably taken up by plasma-membrane transport (Bannai & Kitamura, 1980) . In the cytosol the [35S]cystine is very rapidly reduced to [3SS]cysteine, so that, at least in cystinotic cells, little or no [35S]cystine is detectable in the cytosol even after only 3min of labelling. Significant amounts of cytosolic [3?3]cysteine are transported into the lysosomes or lysosome-like organelles, where, in cystinotic cells, it is then oxidized to [3sS]cystine probably by thiol-disulphide exchange with the pre-existing cystine (Danpure et al., 1984) .
Chloroquine appears to exert its short-term inhibitory effect on the labelling of the intracellular cystine pool in cystinotic cells by interfering with the inward transport of [ 3sS]cysteine across the lysosomal membrane. Although pinocytic uptake of [3sS]cystine appears to be insignificant in the short-term (Thoene et al., 1982) , it may be quantitatively important after long-term labelling. Chloroquine could exert its long-term stimulatory effect on the intracellular [3SS]cystine pool in cystinotic cells either by enhancing the rate of fusion between endocytic vesicles and lysosomes or by expanding the volume of the lysosomal compartment (Danpure, 1981 , 1982a) . Some evidence for the participation of the lysosomal system in the density-regulation of degradation under nutritionally complete conditions has been presented (Cockle & Dean, 1982b) . Protein degradation is also regulated by hormones and nutrients (reviewed by Ballard, 1978) and can be increased markedly in cells in culture by removal of serum from the medium; such 'accelerated' proteolysis has been attributed, on similar grounds, mainly to the lysosomal system (Dean, 1975; Amenta et al., 1977) . Lysosomes also seem to play a slighter role in 'basal' proteolysis in nutritionally complete conditions (Poole et al., 1978; Dean, 1979) . We have studied the effect of the proteinase inhibitor, chymostatin, on protein degradation in normal Swiss 3T3 fibroblasts under both nutritionally complete and nutritionally deficient conditions. This was of interest because of previous indications that cytosol degradation might be significantly affected by this inhibitor (Grinde & Seglen, 1980) . Cells were labelled for 16h at subconfluent densiiies in 75cmZ tissue culture flasks containing lOml of leucine-free MEM*, 10% HIFCS, antibiotics and SpCi of [14C]leucine. Cells were washed twice with 50ml of MEM containing 1OmM-leucine in order to free the intracellular pool of radioactive leucine. Cells were trypsinized and seeded into tissue culture tubes at los 'high cell density' and lo4 'low cell density' cells per tube in 0.5ml of MEM containing 10% HIFCS, antibiotics and 10mM-leucine. After 3h the degradation medium was changed (10% MEM or 1% HIFCS, antibiotics and 1OmM-leucine). Degradation was allowed to proceed for 24 h.
Degradation (%) is expressed as: proteolysis observed in serum deficiency seems to be almost completely inhibited by chymostatin for both cell densities. This inhibition seems to be complete within 6h, indicating that chymostatin permeates cells rapidly. No inhibition of degradation was observed in serum-sufficient conditions in both high and low cell densities. We have found that chymostatin inhibits protein degradation in 3T3 cells in both high and low cell densities under serum-restricted conditions (Fig. 1) . However, the regulation of degradation at high cell density is still retained in the presence of the inhibitor, although inhibition is marked at both cell densities (21% and 26% inhibition for high and low cell densities, respectively). The 'accelerated' Abbreviations used : MEM, Eagle's minimal essential medium; HIFCS, heat-inactivated foetal calf serum; DMSO, dimethylsulphoxide.
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NH4Cl seems to inhibit intracellular proteolysis by raising the intralysosomal pH (Seglen el al., 1981) . It may thus be used in additive experiments to indicate whether another inhibitor has non-lysosomal sites of action. NH4Cl has been found to completely abolish density-regulation of degradation in serum-sufficient conditions whereas in serum depletion only a partial reduction of the regulation in cells at high density was observed even at high concentrations (Cockle & Dean, 1984) . We have found that the inhibitory effect of chymostatin is additive to that of NH4CI in nutritionally deficient conditions. In agreement with previous work
